Members |
targetComponentId |
Rasburicase 1.5mg powder and solvent for infusion vial |
Rasburicase 1.5 mg powder for solution for infusion vial |
Rasburicase 7.5mg infusion (pdr for recon) |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Rasburicase 7.5mg infusion (pdr for recon)+solvent |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Raynaud's phenomenon due to drug and/or poison |
Drug-induced Raynaud's phenomenon (disorder) |
Re-exploration of organ NOC |
Reexploration procedure |
Re-exploration of organ NOC NOS |
Reexploration procedure |
Re-exploration of organ NOC OS |
Reexploration procedure |
Reaction - skin/topical agent |
Adverse reaction to drug |
Reaction - skin/topical agent |
Adverse reaction to drug |
Reaction - vaccine NOS |
Vaccine adverse reaction |
Reaction - vaccine NOS |
Vaccine adverse reaction |
Reactive arthropathy, unspecified |
Reactive arthritis |
Reactive arthropathy, unspecified |
Reactive arthritis |
Reactive cellular changes associated with intrauterine contraceptive device |
Reactive cellular changes caused by intrauterine contraceptive device (finding) |
Readmission for retained products of conception, illegal abortion |
Retained products of conception following induced termination of pregnancy |
Readmission for retained products of conception, legal abortion |
Retained products of conception following induced termination of pregnancy |
Readmission for retained products of conception, spontaneous abortion |
Retained products after miscarriage (disorder) |
Ready for enhanced community coping |
Ready for enhanced community coping |
Ream root canal |
Root canal preparation |
Reanastomosis of fallopian tube NEC |
Tubotubal anastomosis (procedure) |
Reanastomosis of fallopian tube NEC |
Tubotubal anastomosis (procedure) |
Reason not stated concept |
Outdated component (foundation metadata concept) |
Reassurance given NOS |
Reassurance given |
Reassurance given NOS |
Reassurance given |
Reattached finger(s) complication |
Complication of reattached finger |
Recalcification, calcium hydroxide, temporary restoration, per tooth |
Insertion of calcium hydroxide dental cement into tooth |
Recent |
Recent |
Recent Zika virus infection |
Recent Zika virus infection |
Receptionist NOS |
Receptionist |
Receptionist NOS |
Receptionist |
Recession of lateral rectus muscle of eye NEC |
Lateral rectus recession (procedure) |
Recession of lateral rectus muscle of eye NEC |
Lateral rectus recession (procedure) |
Recession of medial rectus muscle of eye NEC |
Medial rectus recession |
Recession of medial rectus muscle of eye NEC |
Medial rectus recession |
Recessive congenital ichthyosiform erythroderma |
Trichothiodystrophy (disorder) |
Recomb human follicle stim horm alpha 1200iu inj pdr+diluent |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
Recombinant alpha glucosidase 50mg powder for injection solution vial |
Product containing only alpha-glucosidase (medicinal product) |
Recombinant antihemophilic factor agent 1000 iu injection solution vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 1000iu powder for injection solution vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 1500 iu injection solution mL vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 1500iu powder for injection solution vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 2000 iu injection solution mL vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 2000iu powder for injection solution vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 250 iu injection solution mL vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 250iu powder for injection solution vial |
Product containing precisely octocog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant antihemophilic factor agent 3000 iu injection solution mL vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 500 iu injection solution mL vial |
Antihemophilic factor agent only product |
Recombinant antihemophilic factor agent 500iu powder for injection solution vial |
Product containing precisely octocog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant coagulation factor IX 1000iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 1000iu powder for injection solution vial |
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant coagulation factor IX 250iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 250iu powder for injection solution vial |
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant coagulation factor IX 500iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
Recombinant coagulation factor IX 500iu powder for injection solution vial |
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant coagulation factor VIIa 120,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant coagulation factor VIIa 240,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant coagulation factor VIIa 60,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial |
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) |
Product containing only follitropin alfa (medicinal product) |
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent |
Product containing only follitropin alfa (medicinal product) |
Recombinant human follicle stimulating hormone alpha 150iu powder and solvent for injection solution ampule |
Follitropin alfa 300 unit/mL solution for injection |
Recombinant human follicle stimulating hormone alpha 37.5iu powder for conventional release solution for injection ampule |
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) |
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon) |
Product containing only follitropin alfa (medicinal product) |
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent |
Product containing only follitropin alfa (medicinal product) |
Recombinant human follicle stimulating hormone alpha 75iu powder and solvent for injection solution ampule |
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Recombinant parathyroid hormone 100micrograms powder for injection solution cartridge and solvent |
Recombinant parathyroid hormone only product |
Recombinant thrombin 20000iu powder for conventional release cutaneous solution |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
Recombinant thrombin 20000iu powder for topical solution + 20mL prefilled syringe diluent |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
Recombinant thrombin 5000iu powder for conventional release cutaneous solution |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
Recombinant thrombin 5000iu powder for topical solution + 5mL prefilled syringe diluent |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
Reconnection and repair of ureter |
Anastomosis of ureter |
Reconstruction of breast using distant flap of skin NEC |
Reconstruction of breast using distant skin flap |
Reconstruction of jaw using pedicled bone flap |
Reconstruction of mandible using bone flap (procedure) |
Reconstruction of organ NOC |
Reconstruction procedure |
Reconstruction of urinary bladder |
Urinary bladder reconstruction |
Reconstruction using forehead flap graft |
Reconstruction using flap from forehead (procedure) |
Records/library clerk NOS |
Record keeping/library clerk |
Records/library clerk NOS |
Record keeping/library clerk |
Recreation manager NOS |
Recreation manager |
Recreation manager NOS |
Recreation manager |
Recreation/sport examination NOS |
History and physical examination, sports participation |
Recreation/sport examination NOS |
History and physical examination, sports participation |
Recreational therapy |
Recreational therapy |
Recreational therapy NOS |
Recreational therapy |
Recreational therapy NOS |
Recreational therapy |
Rectal prednisolone preparations allergy |
Allergy to prednisolone |
Rectally given laxatives |
Laxative (substance) |
Rectocele affecting obstetric care |
Rectocele in pregnancy, childbirth and puerperium (disorder) |
Rectus muscle sprain |
Strain of rectus abdominus muscle (disorder) |
Recurrent benign focal seizures of childhood |
Self-limited focal epilepsy |
Recurrent dislocation of other site, NEC |
Recurrent dislocation of joint |
Recurrent hernia |
Herniated structure (morphologic abnormality) |
Recurrent joint dislocation NOS |
Recurrent dislocation of joint |
Recurrent joint dislocation NOS |
Recurrent dislocation of joint |